Devyser Diagnostics

Devyser Diagnostics R&D per Employee

The R&D Spending per Employee of Devyser Diagnostics (DVYSR.ST) as of Oct 19, 2026 is 187,500.00 SEK. In the previous year, R&D Spending per Employee was 448,958.33 SEK — a change of -58.24% (lower).

R&D per Employee

187,500.00SEK

YoY

-58.24%

Last updated:

R&D Spending per Employee of Devyser Diagnostics is 2025 187,500.00 SEK. R&D Spending per Employee of Devyser Diagnostics was 2024 448,958.33 SEK. It decreases by -58.24% lower compared to the previous year.

The Devyser Diagnostics R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2018
89,833.33 SEK
Jan 1, 2019
103,083.33 SEK
Jan 1, 2020
226,052.08 SEK
Jan 1, 2021
216,833.33 SEK
Jan 1, 2022
298,385.42 SEK
Jan 1, 2023
428,125.00 SEK
Jan 1, 2024
448,958.33 SEK
Jan 1, 2025
187,500.00 SEK
The Devyser Diagnostics R&D per Employee history
YEARR&D per EmployeeYoY
187,500.00SEK-58.24%
448,958.33SEK+4.87%
428,125.00SEK+43.48%
298,385.42SEK+37.61%
216,833.33SEK-4.08%
226,052.08SEK+119.29%
103,083.33SEK+14.75%
89,833.33SEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Devyser Diagnostics Stock analysis

What does Devyser Diagnostics do? Devyser Diagnostics AB is a biotechnology company based in Hagersten, Sweden, operating within the healthcare sector. The company focuses on the development, manufacturing, and sale of genetic testing kits for routine diagnostics. It went public via an IPO on December 10, 2021, and currently employs 96 full-time staff. Devyser Diagnostics' products are utilized for complex DNA testing in areas such as hereditary diseases, oncology, and post-transplantation monitoring, aiding in the diagnosis of genetic conditions and guiding targeted cancer treatments. The company has developed and launched nearly 30 products for routine diagnostic use, including the Devyser Thrombophilia assay and Devyser Resolution XY, which analyzes chromosomes X and Y. These products are distributed directly to end customers or through hired distributors, with sales extending to over 45 countries. The company's website is www.devyser.com, and it is listed on the Stockholm Stock Exchange under the ticker DVYSR.ST. Devyser Diagnostics AB operates with a clear focus on providing diagnostic solutions that support medical professionals in identifying and managing genetic-related health issues through advanced testing technologies. Devyser Diagnostics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Devyser Diagnostics stock

R&D Spending per Employee of Devyser Diagnostics is 187,500.00 SEK in 2025.

R&D Spending per Employee of Devyser Diagnostics changed from 448,958.33 SEK to 187,500.00 SEK, representing a -58.24% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee Devyser Diagnostics since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's Devyser Diagnostics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Workforce — Devyser Diagnostics

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — Devyser Diagnostics